Vdclp+v
Preclinical
Vdclp+v is one of 4 therapeutic programs targeting Acute Lymphoblastic Leukemia, Adult. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
4 competitors in Acute Lymphoblastic Leukemia, Adult
#DrugCompanyPhaseTrials
1Blincyto
AmgenPreclinical
Venclexta
AbbViePreclinical
Consolidation Therapy
IInstitute of Hematology & Blood Diseases Hospital, China
Preclinical
Vdclp+v
IInstitute of Hematology & Blood Diseases Hospital, China
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Vdclp+v. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]